http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013251254-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_553fc890861a31542935915695607748 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32 |
| filingDate | 2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9b7a1b491239c1e2c0bbe130223f119 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_644d305eab56c45e507e9880bedf7341 |
| publicationDate | 2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013251254-B2 |
| titleOfInvention | Pyrimidine substituted purine derivatives |
| abstract | Abstract The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative conditions or disorders including tumours and cancers as well as other disorders or conditions related to or associated with P13 and/or mTOR kinases. |
| priorityDate | 2007-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 303.